Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata [Phase 3]

View source ↗

Summary

Sun Pharmaceutical's study is a Phase 3 trial evaluating the efficacy and safety of deuruxolitinib in adolescents with severe alopecia areata; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Deuruxolitinib (deuruxolitinib)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Alopecia Areata | Phase 3 | Status: RECRUITING